Objective
To assess if the presence of intra-articular Gd-DTPA2- during clinical MR arthrography significantly alters the T2* relaxation times of hip articular cartilage in patients with femoroacetabular impingement (FAI).
Materials and Methods
The institutional review board (IRB) approved this study, and informed consents were obtained in this HIPAA compliant study. T2* mapping of ten patient volunteers (F/M: 7/3, age range 14-49, mean±SD = 33.0 ± 12.2 years) with symptomatic FAI was performed before and after intra-articular Gd-DTPA2- administration. Overall 323 regions of interest (ROIs) were defined in acetabular and femoral cartilage each, pre- and post-Gd injection. Agreement of the relaxation times between pre- and post-Gd was assessed using Krippendorff's alpha coefficient and linear regression through the origin.
Results
Pre-Gd and post-Gd T2* relaxation times in both acetabular and femoral cartilage were found to agree strongly. Specifically, estimated Krippendorff's alphas were greater than 0.8 for both acetabular and femoral cartilage, and linear regressions through the origin yielded estimated slopes very close to 1 and R2 values greater than 0.98.
Conclusions
These results indicate that intra-articular injection of Gd-DTPA2-, along the protocol described in this study, has little effect on T2* values of femoral and acetabular cartilage. The results suggest that T2* mapping can be safely performed as an addition to standard clinical hip imaging protocol utilizing Gd-DTPA2-.